Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xeris Biopharma Holdings (XERS) Amortization - Intangibles: 2021-2025

Historic Amortization - Intangibles for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to $2.7 million.

  • Xeris Biopharma Holdings' Amortization - Intangibles changed negligibly% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $10.8 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Xeris Biopharma Holdings' Amortization - Intangibles stood at $2.7 million, which was down 0.00% from $2.7 million recorded in Q2 2025.
  • Xeris Biopharma Holdings' Amortization - Intangibles' 5-year high stood at $2.7 million during Q1 2022, with a 5-year trough of $550,000 in Q4 2021.
  • In the last 3 years, Xeris Biopharma Holdings' Amortization - Intangibles had a median value of $2.7 million in 2025 and averaged $2.7 million.
  • In the last 5 years, Xeris Biopharma Holdings' Amortization - Intangibles soared by 392.91% in 2022 and then dropped by 0.04% in 2025.
  • Xeris Biopharma Holdings' Amortization - Intangibles (Quarterly) stood at $550,000 in 2021, then surged by 392.91% to $2.7 million in 2022, then remained steady at $2.7 million in 2023, then remained steady at $2.7 million in 2024, then remained steady at $2.7 million in 2025.
  • Its Amortization - Intangibles stands at $2.7 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.7 million for Q1 2025.